41 – 50 of 145
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease : A Randomized, Double-Blind, Multicenter Phase 1 Trial
- Contribution to journal › Article
-
Mark
Nu testas banbrytande en behandling för patienter med Parkinsons sjukdom
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
- Contribution to journal › Article
-
Mark
Real-world effectiveness of fremanezumab for the preventive treatment of migraine : Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
- Contribution to journal › Article
-
Mark
Age-related and amyloid-beta-independent tau deposition and its downstream effects
- Contribution to journal › Article
-
Mark
Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms
- Contribution to journal › Article
-
Mark
Molecular Regulation of the Response of Brain Pericytes to Hypoxia
- Contribution to journal › Scientific review
-
Mark
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
- Contribution to journal › Article
-
Mark
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- Contribution to journal › Article
- 2022
-
Mark
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
- Contribution to journal › Article
